CV Sciences Valuation
| CVSI Stock | USD 0.04 0.00 0.00% |
CV Sciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CV Sciences from evaluating the firm fundamentals such as Shares Outstanding of 150.1 M, shares owned by insiders of 2.01 %, and Return On Asset of -0.52 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors favor purchasing undervalued equities and trading away overvalued equities since, sooner or later, asset prices and their ongoing real values will grow together.
Overvalued
Today
Please note that CV Sciences' price fluctuation is out of control at this time. Calculation of the real value of CV Sciences is based on 3 months time horizon. Increasing CV Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CVSI otc stock is determined by what a typical buyer is willing to pay for full or partial control of CV Sciences. Since CV Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CVSI OTC Stock. However, CV Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.04 | Real 0.0357 | Hype 0.04 | Naive 0.0371 |
The intrinsic value of CV Sciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CV Sciences' stock price.
Estimating the potential upside or downside of CV Sciences helps investors to forecast how CVSI otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CV Sciences more accurately as focusing exclusively on CV Sciences' fundamentals will not take into account other important factors: CV Sciences Total Value Analysis
CV Sciences is currently projected to have valuation of 5.53 M with market capitalization of 7.85 M, debt of 1.4 M, and cash on hands of 1.11 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CV Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.53 M | 7.85 M | 1.4 M | 1.11 M |
CV Sciences Investor Information
The book value of the company was currently reported as 0.01. The company recorded a loss per share of 0.13. CV Sciences had not issued any dividends in recent years. Based on the key indicators related to CV Sciences' liquidity, profitability, solvency, and operating efficiency, CV Sciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.CV Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CV Sciences has an asset utilization ratio of 110.97 percent. This signifies that the OTC Stock is making $1.11 for each dollar of assets. An increasing asset utilization means that CV Sciences is more efficient with each dollar of assets it utilizes for everyday operations.CV Sciences Ownership Allocation
CV Sciences secures a total of 150.1 Million outstanding shares. Roughly 97.99 % of CV Sciences outstanding shares are held by general public with 2.01 percent owned by insiders and only 0.0 (percent) by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.CV Sciences Profitability Analysis
The company reported the previous year's revenue of 20.05 M. Net Loss for the year was (15.55 M) with profit before overhead, payroll, taxes, and interest of 8.62 M.About CV Sciences Valuation
An absolute valuation paradigm, as applied to CVSI OTC Stock, attempts to find the value of CV Sciences based on its fundamental and basic technical indicators. By analyzing CV Sciences's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of CV Sciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CV Sciences. We calculate exposure to CV Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CV Sciences's related companies.CV Sciences, Inc. operates as a life science company in North America. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California. Cv Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 69 people.
8 Steps to conduct CV Sciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates CV Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CV Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain CV Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CV Sciences' revenue streams: Identify CV Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CV Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish CV Sciences' growth potential: Evaluate CV Sciences' management, business model, and growth potential.
- Determine CV Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CV Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CV Sciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 112.5 M | |
| Forward Price Earnings | 15.625 | |
| Retained Earnings | -79.5 M |
Complementary Tools for CVSI OTC Stock analysis
When running CV Sciences' price analysis, check to measure CV Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CV Sciences is operating at the current time. Most of CV Sciences' value examination focuses on studying past and present price action to predict the probability of CV Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CV Sciences' price. Additionally, you may evaluate how the addition of CV Sciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |